The expression of the solute carriers NTCP and OCT-1 is regulated by cholesterol in HepG2 cells

Fundamental and Clinical Pharmacology

Volumn 21, Issue 4, 2007, Pages 445-450

  Dias, Vera ^a   Ribeiro, Vera ^a  

^a UNIVERSITY OF ALGARVE   (Portugal)

Author keywords

Cholesterol; CYP3A4; HepG2 cells; Uptake transporter

Indexed keywords

CHOLESTEROL; CYTOCHROME P450 3A4; MESSENGER RNA; ORGANIC ANION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 1; PROTEIN; PROTEIN SLC10A1; UNCLASSIFIED DRUG;

CELL STRAIN HEPG2; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BIOLOGICAL TRANSPORT; CARCINOMA, HEPATOCELLULAR; CHOLESTEROL; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; ORGANIC CATION TRANSPORTER 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYMPORTERS; TUMOR CELLS, CULTURED;

EID: 34447540370     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2007.00517.x     Document Type: Conference Paper

References (38)

1. Schmitz G., Langmann T. Pharmacogenomics of cholesterol-lowering therapy. Vasc. Pharmacol. (2006) 44 75 89.
2. Handschin C., Podvinee M., Amherd R., Looser R., Ourlin J.C., Meyer U.A. Cholesterol and bile acids regulate xenosensor signalling in drug-mediated induction of cytochromes P450. J. Biol. Chem. (2002) 277 29561 29567.
3. Pikuleva I.A. Cytochrome P450s and cholesterol homeostasis. Pharmacol. Ther. (2006) 112 761 773.
4. Ribeiro V., Cavaco I. Pharmacogenetics of cytochromes P450 in tropical medicine. Curr. Drug Targets (2006) 7 1709 1719.
5. Hagenbuch B., Dawson P. The sodium bile salt cotransport family SLC10. Eur. J. Physiol. (2004) 447 566 570.
6. Fujino H., Saito T., Ogawa S., Kojima J. Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase. J. Pharm. Pharmacol. (2005) 57 1305 1311.
7. Ho R.H., Tirona R.G., Leake B.F. et al. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology (2006) 130 1793 1806.
8. Hagenbuch B., Meier P.J. Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classificaton as OATP/SLCO superfamily, new nomenclature and molecular/functional properties. Eur. J. Physiol. (2004) 447 653 665.
9. Kullak-Ublick G.A., Hagenbuch B., Stieger B. et al. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology (1995) 109 1274 1282.
10. Tamai I., Nezu J., Uchino H. et al. Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem. Biophys. Res. Commun. (2000) 273 251 260.
11. Eckhardt U., Schroeder A., Stieger B. et al. Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably transfected CHO cells. Am. J. Physiol. (1999) 276 G1037 1042.
12. Cvetkovic M., Leake B., Fromm M.F., Wilkinson G.R., Kim R.B. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab. Dispos. (1999) 27 866 871.
13. Gao B., Hagenbuch B., Kullak-Ublick G.A., Benke D., Aguzzi A., Meier P.J. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J. Pharmacol. Exp. Ther. (2000) 294 73 79.
14. Tirona R.G., Kim R.B. Pharmacogenomics of organic anion-transporting polypeptides (OATP). Adv. Drug Deliv. Rev. (2002) 54 1343 1352.
15. Katsura T., Inui K. Intestinal absorption of drugs mediated by drug transporters: mechanisms and regulation. Drug Metab. Pharmacokin. (2003) 18 1 15.
16. Mizuno N., Niwa T., Yotsumoto Y., Sugiyama Y. Impact of drug transporter studies on drug discovery and development. Pharmacol. Rev. (2003) 55 425 461.
17. Koepsell H. Polyspecific organic cation transporters: their functions and interactions with drugs. Trends Pharmacol. Sci. (2004) 25 375 381.
18. Wessler I., Roth E., Deutsch C. et al. Release of non-neuronal acetylcholine from the isolated human placenta is mediated by organic cation transporters. Br. J. Pharmacol. (2001) 134 951 956.
19. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. (1987) 162 156 159.
20. Prueksaritanont T., Gorham L.M., Ma B. et al. In vitro metabolism of simvastatin in humans: identification of metabolizing enzymes and effect of the drug on hepatic P450s. Drug Metab. Dispos. (1997) 25 1191 1199.
21. Pichard L., Gillet G., Fabre I. et al. Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem. Drug Metab. Dispos. (1990) 18 711 719.
22. Plant N.J., Gibson G.G. Evaluation of the toxicological relevance of CYP3A4 induction. Curr. Opin. Drug Discov. Dev. (2003) 6 50 56.
23. Summerfield J.A., Billing B.H., Shackleton C.H. Identification of bile acids in the serum and urine in cholestasis. Evidence for 6alpha-hydroxylation of bile acids in man. Biochem. J. (1976) 154 507 516.
24. George J., Murray M., Byth K., Farrell G.C. Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology (1995) 21 120 128.
25. Stedman C., Robertson G., Coulter S., Liddle C. Feed-forward regulation of bile acid detoxification by CYP3A4 - studies in humanized transgenic mice. J. Biol. Chem. (2004) 279 11336 11343.
26. Schuetz E.G., Strom S., Yasuda K. et al. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J. Biol. Chem. (2001) 276 39411 39418.
27. Libra A., Fernetti C., Lorusso V. et al. Molecular determinants in the transport of a bile acid-derived diagnostic agent in tumoral and nontumoral cell lines of human liver. J. Pharmacol. Exp. Ther. (2006) 319 809 817.
28. Marin J.J., Mangas D., Martinez-Diez M.C., El-Mir M.Y., Briz O., Serrano M.A. Sensitivity of bile acid transport by organic anion-transporting polypeptides to intracellular pH. Biochim. Biophys. Acta (2003) 1611 249 257.
29. Geier A., Dietrich C.G., Gerloff T. et al. Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat. Biochim. Biophys. Acta (2003) 1609 87 94.
30. Denson L.A., Sturm E., Echevarria W. et al. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology (2001) 121 140 147.
31. Li D., Zimmerman T.L., Thevananther S., Lee H.Y., Kurie J.M., Karpen S.J. Interleukin-1 beta-mediated suppression of RXR:RAR transactivation of the Ntcp promoter is JNK-dependent. J. Biol. Chem. (2002) 277 31416 31422.
32. Trauner M., Arrese M., Lee H., Boyer J.L., Karpen S.J. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J. Clin. Invest. (1998) 101 2092 2100.
33. Ganguly T.C., O'Brien M.L., Karpen S.J., Hyde J.F., Suchy F.J., Vore M. Regulation of the rat liver sodium-dependent bile acid cotransporter gene by prolactin. Mediation of transcriptional activation by Stat5. J. Clin. Invest. (1997) 99 2906 2914.
34. Staudinger J.L., Goodwin B., Jones S.A. et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl Acad. Sci. USA (2001) 98 3369 3374.
35. Jung D., Hagenbuch B., Gresh L., Pontoglio M., Meier P.J., Kullak-Ublick G.A. Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha. J. Biol. Chem. (2001) 276 37206 37214.
36. Denk G.U., Soroka C.J., Mennone A., Koepsell H., Beuers U., Boyer J.L. Down-regulation of the organic cation transporter 1 of rat liver in obstructive cholestasis. Hepatology (2004) 39 1382 1389.
37. Ciarimboli G., Struwe K., Arndt P. et al. Regulation of the human organic cation transporter hOCT1. J. Cell. Physiol. (2004) 201 420 428.
38. Kallen J.A., Schlaeppi J.M., Bitsch F. et al. X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha. Structure (2002) 10 1697 1707.